REPRODUCIBLE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA BY FLOW CYTOMETRY: AN EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC) & EUROPEAN SOCIETY FOR CLINICAL CELL ANALYSIS (ESCCA) HARMONISATION PROJECT

Rawstron ACKreuzer K-ASoosapilla ASpacek MStehlikova OGambell PMcIver-Brown NVillamor NPsarra KArroz MMilani Rde la Serna JCedena MTJaksic ONomdedeu JMoreno CRigolin GMCuneo AJohansen PJohnsen HERosenquist RUtoft Niemann CKern WWesterman DTrneny MMulligan SDoubek MPospisilova SHillmen POscier DHallek MGhia P, and Montserrat E.

Cytometry Part B 2018; 94B: 121–128.

ERIC RECOMMENDATIONS FOR TP53 MUTATION ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA – UPDATE ON METHODOLOGICAL APPROACHES AND RESULTS INTERPRETATION

Malcikova J, Tausch E, Rossi D, Sutton LA, Soussi T, Zenz T, Kater A, Utoft Niemann C, Gonzalez D, Davi F, Gonzalez Diaz M, Moreno C, Gaidano G, Stamatopoulos K, Rosenquist R, Stilgenbauer S, Ghia P, Pospisilova S & on behalf of the European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) – TP53 network

Leukemia (2018) doi:10.1038/s41375-017-0007-7

EFFICACY OF BENDAMUSTINE AND RITUXIMAB AS FIRST SALVAGE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA AND INDIRECT COMPARISON WITH IBRUTINIB: A GIMEMA, ERIC AND UNK CLL FORMU STUDY

Cuneo A, Follows G, Rigolin G M, Piciocchi A, Tedeschi A, Trentin L, Medina Perez A, Coscia M, Laurenti L, Musuraca G, Farina L, Rivas Delgado A, Orlandi E A, Galieni P, Romana Mauro F, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, A Eyre T, Kennedy B, Bowles K M, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P

Haematologica 2018 April 19